Matches in Wikidata for { <http://www.wikidata.org/entity/Q57830826> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- Q57830826 description "im Mai 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57830826 description "scholarly article by Kim Lauper et al published 5 May 2018 in Annals of the Rheumatic Diseases" @default.
- Q57830826 description "wetenschappelijk artikel" @default.
- Q57830826 description "наукова стаття, опублікована в травні 2018" @default.
- Q57830826 name "Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-mod" @default.
- Q57830826 name "Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-mod" @default.
- Q57830826 type Item @default.
- Q57830826 label "Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-mod" @default.
- Q57830826 label "Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-mod" @default.
- Q57830826 prefLabel "Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-mod" @default.
- Q57830826 prefLabel "Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-mod" @default.
- Q57830826 P1433 Q57830826-50A0FF25-F07C-48CD-9881-263C5CEC8061 @default.
- Q57830826 P1476 Q57830826-D213EF03-2543-47EC-A65F-1CB2FDACD231 @default.
- Q57830826 P2093 Q57830826-01B3CAA0-A8CC-4488-A32F-49982CB8F56C @default.
- Q57830826 P2093 Q57830826-15ADB84C-8E2D-410C-82C1-9A8320876E14 @default.
- Q57830826 P2093 Q57830826-7CB88918-418B-4B81-A66E-745A20C2AF49 @default.
- Q57830826 P2093 Q57830826-908B7365-B3C4-4252-98AC-3AA5327863E6 @default.
- Q57830826 P2093 Q57830826-984227F2-EE29-496D-A550-63589D99B8A7 @default.
- Q57830826 P2093 Q57830826-98B5C1C0-3B35-4D27-9C95-0C09DF59F9BB @default.
- Q57830826 P2093 Q57830826-A9C3BA18-9104-4847-BCC8-7D0524D3B74A @default.
- Q57830826 P2093 Q57830826-CF44EDC6-FB34-4D97-B66E-6296134CCAF8 @default.
- Q57830826 P2093 Q57830826-D652228B-C8FE-43D7-BF00-56843DC853A6 @default.
- Q57830826 P2093 Q57830826-DE96994C-F37F-4EDF-8266-BCBEC8FB6BFB @default.
- Q57830826 P304 Q57830826-2A864207-74D0-4960-8341-AEFD52BC367A @default.
- Q57830826 P31 Q57830826-92C84C33-7161-4894-8BA9-2A95578484B6 @default.
- Q57830826 P356 Q57830826-262CB3CB-FEBF-473D-956D-EDC536B5BF3F @default.
- Q57830826 P407 Q57830826-23ECD745-FB0A-454C-B949-F459ED5BD155 @default.
- Q57830826 P433 Q57830826-62D4B57E-F5D0-42F3-9B82-33E018204D32 @default.
- Q57830826 P478 Q57830826-894AD470-BA7A-4609-842F-770DD1A50111 @default.
- Q57830826 P50 Q57830826-02B27A6C-EA60-49B3-9B6D-FE976E146118 @default.
- Q57830826 P50 Q57830826-229FE6F4-7F82-4230-A9BB-0DA1842A2C3D @default.
- Q57830826 P50 Q57830826-42C58D66-E5AC-479A-971C-07FC7BD7A85F @default.
- Q57830826 P50 Q57830826-45DBAB40-99F2-4E3D-B6C7-03599B547304 @default.
- Q57830826 P50 Q57830826-635259C0-F3B8-49C9-B686-F2157F719501 @default.
- Q57830826 P50 Q57830826-ECA01AC0-B6BA-4CBA-91C0-A1FD0A455E83 @default.
- Q57830826 P577 Q57830826-6BE47D15-FAC9-4646-9F93-DECA8813FBE5 @default.
- Q57830826 P698 Q57830826-4792ECD8-36FB-44A9-9892-249960518C06 @default.
- Q57830826 P921 Q57830826-19035C49-BB6B-4B1A-A710-D8908B9721FC @default.
- Q57830826 P921 Q57830826-7D1FBA68-5310-4410-8556-3A52A333708D @default.
- Q57830826 P921 Q57830826-92778D91-FC2E-49BA-BCE5-EC552516EA61 @default.
- Q57830826 P921 Q57830826-AAB5BFDC-2AF3-4ECF-BE4D-EB1170923A80 @default.
- Q57830826 P921 Q57830826-EEA5BA4B-8BD5-4B7E-A808-F54C059DD65F @default.
- Q57830826 P356 ANNRHEUMDIS-2017-212845 @default.
- Q57830826 P698 29730637 @default.
- Q57830826 P1433 Q4767876 @default.
- Q57830826 P1476 "Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-mod" @default.
- Q57830826 P2093 "Catalin Codreanu" @default.
- Q57830826 P2093 "Delphine Sophie Courvoisier" @default.
- Q57830826 P2093 "Florenzo Iannone" @default.
- Q57830826 P2093 "Galina Lukina" @default.
- Q57830826 P2093 "Karel Pavelka" @default.
- Q57830826 P2093 "Khaled Sarsour" @default.
- Q57830826 P2093 "Maria Victoria Hernández" @default.
- Q57830826 P2093 "Sara L Gale" @default.
- Q57830826 P2093 "Yves Luder" @default.
- Q57830826 P2093 "Žiga Rotar" @default.
- Q57830826 P304 "1276-1282" @default.
- Q57830826 P31 Q13442814 @default.
- Q57830826 P356 "10.1136/ANNRHEUMDIS-2017-212845" @default.
- Q57830826 P407 Q1860 @default.
- Q57830826 P433 "9" @default.
- Q57830826 P478 "77" @default.
- Q57830826 P50 Q115061092 @default.
- Q57830826 P50 Q115061106 @default.
- Q57830826 P50 Q51064290 @default.
- Q57830826 P50 Q57830864 @default.
- Q57830826 P50 Q65660760 @default.
- Q57830826 P50 Q66753936 @default.
- Q57830826 P577 "2018-05-05T00:00:00Z" @default.
- Q57830826 P698 "29730637" @default.
- Q57830826 P921 Q101929 @default.
- Q57830826 P921 Q18032037 @default.
- Q57830826 P921 Q187255 @default.
- Q57830826 P921 Q327657 @default.
- Q57830826 P921 Q425154 @default.